IL83421A - Method of isolating and purifying human b lymphotropic virus - Google Patents
Method of isolating and purifying human b lymphotropic virusInfo
- Publication number
- IL83421A IL83421A IL83421A IL8342187A IL83421A IL 83421 A IL83421 A IL 83421A IL 83421 A IL83421 A IL 83421A IL 8342187 A IL8342187 A IL 8342187A IL 83421 A IL83421 A IL 83421A
- Authority
- IL
- Israel
- Prior art keywords
- virus
- aids
- human
- analysis
- examining
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 8
- 208000030507 AIDS Diseases 0.000 abstract 5
- 210000004027 cell Anatomy 0.000 abstract 2
- 241001529453 unidentified herpesvirus Species 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000288906 Primates Species 0.000 abstract 1
- 238000002105 Southern blotting Methods 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000001086 cytosolic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
- C12N2710/16521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
- C12N2710/16551—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89242386A | 1986-08-04 | 1986-08-04 | |
| US90160286A | 1986-08-29 | 1986-08-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL83421A0 IL83421A0 (en) | 1988-01-31 |
| IL83421A true IL83421A (en) | 1992-01-15 |
Family
ID=27129014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL83421A IL83421A (en) | 1986-08-04 | 1987-08-03 | Method of isolating and purifying human b lymphotropic virus |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0318498B1 (de) |
| JP (1) | JP2559783B2 (de) |
| AT (1) | ATE86308T1 (de) |
| CA (1) | CA1340403C (de) |
| DE (1) | DE3784513T2 (de) |
| IL (1) | IL83421A (de) |
| WO (1) | WO1988000980A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1948788A (en) * | 1987-06-01 | 1989-01-04 | Baylor College Of Medicine | Expression of immunologically active proteins of human b-lymphotropic virus |
| US4994386A (en) * | 1987-07-13 | 1991-02-19 | Pharmacia Diagnostics, Inc. | Production of HBLV virus in the HSB-2 cell line |
| US5602023A (en) * | 1992-03-24 | 1997-02-11 | Csatary; Laszlo K. | Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same |
| WO1993018790A1 (en) * | 1992-03-24 | 1993-09-30 | Csatary Laszlo K | Vaccine containing live virus for therapy of viral diseases and malignancies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU583473B2 (en) * | 1983-04-27 | 1989-05-04 | President And Fellows Of Harvard College | Method and products for detection of human t cell leukemia virus |
| US4725669A (en) * | 1984-11-09 | 1988-02-16 | President And Fellows Of Harvard College | Assay for detecting infection by human T-cell lymphotropic virus-III |
| US4994386A (en) * | 1987-07-13 | 1991-02-19 | Pharmacia Diagnostics, Inc. | Production of HBLV virus in the HSB-2 cell line |
-
1987
- 1987-07-29 EP EP87905357A patent/EP0318498B1/de not_active Expired - Lifetime
- 1987-07-29 JP JP62504948A patent/JP2559783B2/ja not_active Expired - Lifetime
- 1987-07-29 WO PCT/US1987/001815 patent/WO1988000980A1/en not_active Ceased
- 1987-07-29 DE DE8787905357T patent/DE3784513T2/de not_active Expired - Lifetime
- 1987-07-29 AT AT87905357T patent/ATE86308T1/de not_active IP Right Cessation
- 1987-08-03 IL IL83421A patent/IL83421A/xx not_active IP Right Cessation
- 1987-08-04 CA CA000543652A patent/CA1340403C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE86308T1 (de) | 1993-03-15 |
| AU612330B2 (en) | 1991-07-11 |
| EP0318498A1 (de) | 1989-06-07 |
| AU7853487A (en) | 1988-02-24 |
| EP0318498A4 (de) | 1990-02-26 |
| EP0318498B1 (de) | 1993-03-03 |
| DE3784513D1 (de) | 1993-04-08 |
| DE3784513T2 (de) | 1993-09-16 |
| JP2559783B2 (ja) | 1996-12-04 |
| JPH02500324A (ja) | 1990-02-08 |
| WO1988000980A1 (en) | 1988-02-11 |
| IL83421A0 (en) | 1988-01-31 |
| CA1340403C (en) | 1999-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Klein | The relationship of the virus to nasopharyngeal carcinoma | |
| Orth et al. | Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis | |
| Bonneau et al. | Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity | |
| Plummer et al. | Type 1 and type 2 herpes simplex viruses: serological and biological differences | |
| Lewis et al. | Protection against feline leukemia by vaccination with a subunit vaccine | |
| AU2684792A (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic | |
| KATSUKI et al. | Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells | |
| Jablonska et al. | Epidermodysplasia verruciformis versus disseminated verrucae planae: Is epidermodysplasia verruciformis a generalized infection with wart virus? | |
| Notter et al. | Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens | |
| Lange et al. | Longitudinal study of Epstein‐Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease | |
| ES8706824A1 (es) | Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia. | |
| Roos et al. | Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus | |
| IL83421A (en) | Method of isolating and purifying human b lymphotropic virus | |
| Beutner et al. | Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans | |
| Ten Napel et al. | Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test | |
| Astier-Gin et al. | Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states | |
| Kienzler | Humoral immunity to human papillomaviruses | |
| RU2073524C1 (ru) | Живая рекомбинантная вакцина для профилактики гепатита в и натуральной оспы для накожного применения и способ ее получения | |
| Martin et al. | Complement-fixing antigens produced by varicella-zoster virus in tissue culture | |
| Neubauer et al. | Antibody responses to Herpesvirus papio antigens in baboons with lymphoma | |
| Lutton et al. | Cellular immune responses in mice challenged with an amyocarditic variant of coxsackievirus B3 | |
| Schmidt et al. | Complement-fixing reactivity of varicella-zoster virus subunit antigens with sera from homotypic infections and heterotypic herpes simplex virus infections | |
| Henderson et al. | Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells | |
| EP0089854A2 (de) | DNS Viren-Vakzin | |
| Adler et al. | Immunity in wart resolution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |